Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Yardley DA. Breast Cancer Targets Therapy. 2015:7;293–301.On page 300, Disclosure section, “The author reports no conflicts of interest in the work” has been updated since publication and should read “Dr Yardley reports nonfinancial support from Celgene pertai...
Enregistré dans:
Auteur principal: | Yardley DA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b58e87eb8d3547e6b2991eacd2d9bdeb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Taxanes in the elderly patient with metastatic breast cancer
par: Yardley DA
Publié: (2015) -
A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
par: Jiaojiao Suo, et autres
Publié: (2021) -
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
par: Linda T. Vahdat, et autres
Publié: (2021) -
Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
par: Sawaki M
Publié: (2014) -
Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites
par: Soojin Cha, et autres
Publié: (2021)